Skip to content

Clinical trials

Pulmonary Embolism trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Embolism Country / region: Germany Clear all

53 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20041
20053
20077
20081
20092
20101
20112
20122
20134
20142
20165
20171
20183
20203
20215
20224
20231
20244

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Terminated8
Recruiting5
Active, not recruiting4
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer7
Boston Scientific Corporation4
Inari Medical4
Bristol-Myers Squibb3
Daiichi Sankyo3
Anthos Therapeutics, Inc.2
Assistance Publique - Hôpitaux de Paris2
Johannes Gutenberg University Mainz2
Prof. Stavros Konstantinides, MD2
Sanofi2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Embolism53
Venous Thrombosis24
Venous Thromboembolism14
Thrombosis9
Atrial Fibrillation4
Thromboembolism4
COVID-193
Neoplasms3
Embolism2
Embolism and Thrombosis2

Trials

Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.